Press Release – New York, NY – October 6, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented Entero Therapeutics, Inc. (Nasdaq: ENTO), a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal diseases, in its acquisition of GRID AI Corp, a grid-edge, AI-driven software and device platform that enables utilities, retailers, and large power users to dynamically manage load and distributed energy resources.
The SRFC team was led by partners Ross Carmel, Carl Kleidman and Avital Perlman, with associate Lony Leung.